Stock Events

Stock Events

BIOSYNTECH INC 

$0.000010
2
-$0.00-99.67% Monday 20:00

Statistics

Day High
0.000001
Day Low
0.000001
52W High
0.00001
52W Low
0.000001
Volume
642
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

13FebExpected
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
Q4 2022
0
0.33
0.67
1
Expected EPS
0
Actual EPS
N/A

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap116.77B
Medtronic is a major player in the medical devices sector, directly competing with Biosyntech in areas such as implantable biomedical devices.
Stryker
SYK
Mkt Cap126.84B
Stryker specializes in medical technologies, including orthopedic products, which overlap with Biosyntech's offerings in biotechnology-based orthopedic solutions.
Zimmer Biomet
ZBH
Mkt Cap19.25B
Zimmer Biomet Holdings focuses on musculoskeletal healthcare, competing in the same space as Biosyntech's biotech-enhanced orthopedic products.
Boston Scientific
BSX
Mkt Cap67.88B
Boston Scientific competes in developing advanced medical devices that can be in direct competition with Biosyntech's innovative biomedical solutions.
Abbott Laboratories
ABT
Mkt Cap194.62B
Abbott Laboratories operates in various healthcare segments, including medical devices, which can compete with Biosyntech's product lines.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson's medical devices division offers products that could compete with Biosyntech's technologies in healthcare solutions.
Intuitive Surgical
ISRG
Mkt Cap131.63B
Intuitive Surgical, known for its robotic surgical systems, competes in the innovative medical device market, relevant to Biosyntech's tech-focused approach.
Edwards Lifesciences
EW
Mkt Cap52B
Edwards Lifesciences specializes in heart valves and hemodynamic monitoring, competing in the high-tech medical device market similar to Biosyntech.

About

BioSyntech, Inc. develops biotherapeutic thermogels for tissue repair and therapeutic delivery. Its lead products in development include BST-CarGel, a biodegradable gel for cartilage repair; BST-InPod for heel pain relief; BST-DermOn for chronic wound healing; BST-Ossifil for bone filling; BST-Ossifix for bone structural support; and BST-Disc for intervertebral disc restoration. The company's products also comprise BST-Gel-based injectable products that deliver biotherapeutics to their targeted site of action; Arthro-BST, an arthroscopic device used for the non-destructive evaluation of cartilage degradation and/or repair; and Mach-1, a micromechanical testing system for evaluating the mechanical properties of tissues and materials. In addition, it manufactures ultra pure chitosans under the Ultrasan name; and offers manufacturing and analytical services. The company was incorporated in 1994 and is based in Laval, Canada. On May 12, 2010, Biosyntech Inc. filed for administration under the Bankruptcy and Insolvency Act. Biosyntech Inc. is in reorganization.
Show more...
CEO
Dr. Amine Selmani Ph.D.
Country
Canada

Listings

0 Comments

Share your thoughts

FAQ

What is BIOSYNTECH INC stock price today?▼
The current price of BSYI is $0.00 USD — it has decreased by -99.67% in the past 24 hours. Watch BIOSYNTECH INC stock price performance more closely on the chart.
What is BIOSYNTECH INC stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange BIOSYNTECH INC stocks are traded under the ticker BSYI.
Is BIOSYNTECH INC stock price growing?▼
BSYI stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year BIOSYNTECH INC has showed a +0% increase.
In which sector is BIOSYNTECH INC located?▼
BIOSYNTECH INC operates in the Health & Wellness sector.
When did BIOSYNTECH INC complete a stock split?▼
BIOSYNTECH INC has not had any recent stock splits.
Where is BIOSYNTECH INC headquartered?▼
BIOSYNTECH INC is headquartered in Laval, Canada.